🇰🇷 South Korea Country × Condition
parkinson disease Clinical Trials in South Korea
Active clinical trials for parkinson disease with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT07371338 Phase 1
Recruiting
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients
Enrollment
6 pts
Country
🇰🇷 South Korea
Innopeutics Corporation
View Trial → NCT01799915
Recruiting
Natural History Study of Synucleinopathies
Enrollment
800 pts
Country
🇰🇷 South Korea
NYU Langone Health
View Trial → NCT04706234
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Enrollment
350 pts
Country
🇰🇷 South Korea
Kliniken Beelitz GmbH
View Trial → Frequently Asked Questions
How many parkinson disease clinical trials are active in South Korea?
There are currently 3 active clinical trials for parkinson disease with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a parkinson disease clinical trial in South Korea?
To join a parkinson disease clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in South Korea?
Active parkinson disease trials in South Korea span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology